Guanidine Hydrochloride → HCID 57900265, compound

HRID 627989Notes

Reaction equation

HRID 627989 reaction equation
[Cl:1][C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][C:3]=1[C:8](=[CH:25]N(C)C)[C:9]([C:11]1[S:24][C:14]2[C:15]3[CH:23]=[CH:22][CH:21]=[CH:20][C:16]=3[O:17][CH2:18][CH2:19][C:13]=2[CH:12]=1)=O.C(=O)([O-])[O-].[K+].[K+].Cl.[NH2:36][C:37]([NH2:39])=[NH:38]>C(O)C>[Cl:1][C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][C:3]=1[C:8]1[C:9]([C:11]2[S:24][C:14]3[C:15]4[CH:23]=[CH:22][CH:21]=[CH:20][C:16]=4[O:17][CH2:18][CH2:19][C:13]=3[CH:12]=2)=[N:38][C:37]([NH2:39])=[N:36][CH:25]=1

Participants

5

Conditions

Temperature
90 °C

Procedure

To a solution of crude 2-(2-chlorophenyl)-1-(4,5-dihydrobenzo[b]thieno[2,3-d]oxepin-2-yl)-3-(dimethylamino)prop-2-en-1-one (ca. 0.22 mmol) in ethanol (2 mL) was added potassium carbonate (87 mg, 0.63 mmol) and then guanidine hydrochloride (40 mg, 0.42 mmol). The whole was sealed and heated at 90° C. for 8 h, cooled to room temperature and concentrated. The residue was diluted with water and extracted with ethyl acetate. The combined organics were purified by reverse phase HPLC to give 282. MS (ESI) 406.2

Workup

  1. customThe whole was sealed
  2. temperaturecooled to room temperature
  3. concentrationconcentrated
  4. additionThe residue was diluted with water
  5. extractionextracted with ethyl acetate
  6. customThe combined organics were purified by reverse phase HPLC

Sources & evidence

ORD record
ord-c5feb65f9cda45e5ada0b527d8c1ac28
Source dataset
uspto-grants-2016_04
Patent number
US09309265B2

Reaction notes

Loading…